{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:16:29Z","timestamp":1769688989117,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.clindermatol.2003.12.023","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T18:52:12Z","timestamp":1088794332000},"page":"157-166","source":"Crossref","is-referenced-by-count":76,"title":["Drug-induced lupus erythematosus"],"prefix":"10.1016","volume":"22","author":[{"given":"Dimitar","family":"Antonov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Kazandjieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doncho","family":"Etugov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitar","family":"Gospodinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Tsankov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2003.12.023_BIB1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0738-081X(98)00007-8","article-title":"Drug-induced lupus erythematosus","volume":"16","author":"Pramatarov","year":"1998","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB2","first-page":"150","article-title":"Sensitivity to sulfadiazine resembling acute disseminated lupus erythematosus","volume":"51","author":"Hoffman","year":"1945","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.CIR.8.6.829","article-title":"Studies on the control of hypertention by Hyphex. II. Toxic reactions and side effects","volume":"8","author":"Morrow","year":"1953","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1056\/NEJM198806023182209","article-title":"Drug-related lupus","volume":"318","author":"Hess","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","article-title":"Hydralazine-induced systemic lupus erythematosus","volume":"1","author":"Batchelor","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2133.2000.03357.x","article-title":"Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome","volume":"142","author":"Dunphy","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/36.10.1089","article-title":"Predisposing factors in sulphasalazine-induced systemic lupus erythematosus","volume":"36","author":"Gunnarsson","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(89)92506-3","article-title":"Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus","volume":"1","author":"Speirs","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(96)03594-9","article-title":"Current trends in drug-induced autoimmunity","volume":"119","author":"Uetrecht","year":"1997","journal-title":"Toxicology"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI119356","article-title":"Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus","volume":"99","author":"Kretz-Rommel","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1567-5769(01)00046-7","article-title":"Gender differences in autoimmunity","volume":"1","author":"Rider","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB12","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.167.4.1886","article-title":"Cutting edge","volume":"167","author":"Grimaldi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1471-4906(02)02204-4","article-title":"Molecular and clinical evidence of the role of estrogen in lupus","volume":"23","author":"Vidaver","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/berh.2002.0225","article-title":"Reproductive health in SLE","volume":"16","author":"Askanase","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF therapy of rheumatoid arthritis","volume":"19","author":"Feldman","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB16","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.7725110","article-title":"Neutrophils and drug metabolism","volume":"268","author":"von Schmiedeberg","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/73152","article-title":"Disruption of positive selection of thymocytes causes autoimmunity","volume":"6","author":"Kretz-Rommel","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/73101","article-title":"Positive selection for autoimmunity","volume":"6","author":"Datta","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.162.2.813","article-title":"Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus","volume":"162","author":"Kretz-Rommel","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/cimm.2001.1774","article-title":"Early cellular events in systemic autoimmunity driven by chromatin-reactive T cells","volume":"208","author":"Kretz-Rommel","year":"2001","journal-title":"Cell Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrg887","article-title":"Chromatin modification and epigenetic reprogramming in mammalian development","volume":"3","author":"Li","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB24","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.10234","article-title":"Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus","volume":"46","author":"Lu","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB25","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1172\/JCI118743","article-title":"Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice","volume":"97","author":"Yung","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB26","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.154.6.3025","article-title":"Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo","volume":"154","author":"Yung","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB27","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/art.1780400811","article-title":"Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo","volume":"40","author":"Yung","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0049-0172(75)90024-4","article-title":"Drug-induced systemic lupus erythematosus","volume":"5","author":"Lee","year":"1975","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB29","unstructured":"Kauffman CL, Sabbagh AK. Lupus Erythematosus, Drug-Induced. eMedicine Journal 2001;2(11). http:\/\/www.emedicine.com\/derm\/topic107.htm"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00045391-200203000-00012","article-title":"Isoniazid-induced lupus erythematosus presenting with cardiac tamponade","volume":"9","author":"Siddiqui","year":"2002","journal-title":"Am J Ther"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.117.2.597","article-title":"Carbamazepine-induced systemic lupus erythematosus presenting as cardiac tamponade","volume":"117","author":"Verma","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1378\/chest.116.1.212","article-title":"Drugs and the pleura","volume":"116","author":"Morelock","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/anr.1780320508","article-title":"Synovial fluid characteristics and the lupus erythematosus cell phenomenon in drug-induced lupus. Findings in three patients and review of pertinent literature","volume":"32","author":"Vivino","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1067\/mjd.2001.116583","article-title":"Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized","volume":"45","author":"Callen","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB35","first-page":"1001","article-title":"Can hydrochlorothiazide cause lupus?","volume":"22","author":"Rich","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0002-9343(01)01102-0","article-title":"Atorvastatin-induced reversible positive antinuclear antibodies","volume":"112","author":"Jimenez-Alonso","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00002281-200001000-00008","article-title":"Musculoskeletal and systemic reactions to biological therapeutic agents","volume":"12","author":"Watts","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(02)09798-2","article-title":"Drug-induced systemic lupus erythematosus and TNF-alpha blockers","volume":"360","author":"Ferraccioli","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0140-6736(92)92810-3","article-title":"Minocycline-related lupus","volume":"340","author":"Matsuura","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2001.112218","article-title":"Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris","volume":"44","author":"Schaffer","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archinte.159.5.493","article-title":"Minocycline and lupuslike syndrome in acne patients","volume":"159","author":"Sturkenboom","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/40.3.329","article-title":"Minocycline-induced lupus","volume":"40","author":"Lawson","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB43","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes","volume":"28","author":"Elkayam","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(98)00325-8","article-title":"Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena","volume":"105","author":"Elkayam","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.55.10.769","article-title":"Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA","volume":"55","author":"Elkayam","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome","volume":"312","author":"Gough","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB47","first-page":"471","article-title":"Drug-induced lupus associated with COL-3","volume":"137","author":"Ghate","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB48","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.151.8.1667","article-title":"Lovastatin-induced lupus erythematosus","volume":"151","author":"Ahmad","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.152.5.1093a","article-title":"Lupuslike syndrome associated with simvastatin","volume":"152","author":"Bannwarth","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(98)85019-8","article-title":"Fatal lupus-like syndrome and ARDS induced by fluvastatin","volume":"352","author":"Sridhar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB51","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(05)60116-X","article-title":"Lupus-like syndrome associated with simvastatin","volume":"352","author":"Hanson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","article-title":"Immune-mediated complications during interferon therapy in hematological patients","volume":"107","author":"Raanani","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0300-483X(95)03124-X","article-title":"Immune-mediated side-effects of cytokines in humans","volume":"105","author":"Vial","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB54","first-page":"1621","article-title":"Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis","volume":"18","author":"Graninger","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB55","first-page":"352","article-title":"Subacute cutaneous lupus erythematosus associated with interferon beta-1a","author":"Nousari","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","article-title":"Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine","volume":"137","author":"Callen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB57","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"44","author":"Bonsmann","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.1998.02194.x","article-title":"Terbinafine-induced lupus erythematosus","volume":"138","author":"Murphy","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2133.1998.2576q.x","article-title":"Terbinafine-induced subacute cutaneous lupus erythematosus","volume":"139","author":"Brooke","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB60","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2133.1998.2576r.x","article-title":"Exacerbation of systemic lupus erythematosus induced by terbinafine","volume":"139","author":"Holmes","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB61","doi-asserted-by":"crossref","unstructured":"Phillips R, Nash M. Terbinafine and lupus erythematosus a chance association? Dermatol Online J 1999;5(2):9. http:\/\/dermatology.cdlib.org\/DOJvol5num2\/correspondence\/terbinafine.html","DOI":"10.5070\/D30C82J69B"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB62","first-page":"54","article-title":"Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT)","volume":"11","author":"Yoshimasu","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB63","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.114.10.1498","article-title":"Photosensitivity due to a fluorouracil derivative","volume":"114","author":"Horio","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB64","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.1780371109","article-title":"Systemic lupus erythematosus induced by ovulation induction treatment","volume":"37","author":"Ben-Chetrit","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rheumatology\/38.4.372","article-title":"Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis?","volume":"38","author":"Yang","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/152460901300139989","article-title":"Lupus","volume":"10","author":"Greenstein","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB67","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(01)05731-2","article-title":"Systemic lupus erythematosus","volume":"358","author":"Grant","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB68","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/art.1780400505","article-title":"Past use of oral contraceptives and the risk of developing systemic lupus erythematosus","volume":"40","author":"Sanchez-Guerrero","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB69","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-122-6-199503150-00005","article-title":"Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus","volume":"122","author":"Sanchez-Guerrero","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB70","first-page":"1515","article-title":"Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus","volume":"25","author":"Meier","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339400300104","article-title":"Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)","volume":"3","author":"Arden","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB72","first-page":"2149","article-title":"Hormone replacement therapy in systemic lupus erythematosus","volume":"24","author":"Kreidstein","year":"1997","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2003.12.023_BIB73","first-page":"75","article-title":"Contraception with the latest estroprogestagens in women suffering from systemic lupus erythematosus","volume":"53","author":"Rampone","year":"2001","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB74","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB75","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(02)07718-8","article-title":"Adverse reactions to TNF-\u03b1 inhibitors in rheumatoid arthritis","volume":"359","author":"Day","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB76","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB77","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(02)09800-8","article-title":"Drug-induced systemic lupus erythematosus and TNF-alpha blockers","volume":"360","author":"Mohan","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB78","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/40.11.1317","article-title":"Etanercept-induced subacute cutaneous lupus erythematosus","volume":"40","author":"Bleumink","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB79","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-137-7-200210010-00030","article-title":"Infliximab-induced systemic lupus erythematosus","volume":"137","author":"Ali","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB80","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.10271","article-title":"Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent","volume":"46","author":"Fautrel","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB81","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-4362.1990.tb03471.x","article-title":"Lupus erythematosus-like eruption due to D-penicillamine in progressive systemic sclerosis","volume":"29","author":"Tsankov","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB83","first-page":"10","article-title":"Streptomycin as a factor producing and aggravating lupus erythematosus","volume":"34","author":"Popkhristov","year":"1960","journal-title":"Vestn Dermatol Venerol (Moscow)"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB84","unstructured":"Gospodinov D, Tonova T, Jablanski K, et al. Lupus erythematosus medicamentosus. Dermatol i Venerol (Sofia) 1991; Suppl 1:51\u20133"},{"key":"10.1016\/j.clindermatol.2003.12.023_BIB85","first-page":"48","article-title":"Lupus erythematosus medicamentosus\u2014differential-diagnostic criteria","volume":"2","author":"Berova","year":"1990","journal-title":"Dermatol i Venerol (Sofia)"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X03001433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T23:07:38Z","timestamp":1682723258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X03001433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0738081X03001433"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2003.12.023","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}